A Chemical Approach on Drugs that are Under Evaluation as Potential COVID-19’s Treatment

Jessica S. Pizzo, Patricia D. S. Santos, Carlos R. Senes, Victor H. M. Cruz, Patrícia M. Souza, Matheus C. de Castro, Oscar O. Santos-Junior, Jesuí V. Visentainer
{"title":"A Chemical Approach on Drugs that are Under Evaluation as Potential COVID-19’s Treatment","authors":"Jessica S. Pizzo, Patricia D. S. Santos, Carlos R. Senes, Victor H. M. Cruz, Patrícia M. Souza, Matheus C. de Castro, Oscar O. Santos-Junior, Jesuí V. Visentainer","doi":"10.21577/1984-6835.20220061","DOIUrl":null,"url":null,"abstract":"A novel SARS-CoV-2 coronavirus, the virus responsible for COVID-19, is a public health emergency of international concern since this infection spreads quickly through human-to-human transmission. Several drugs are being studied by researchers worldwide as an effective antiviral agent against this coronavirus. Therefore, most studies are focusing on drugs that have been already used earlier on the treatment of other diseases. Therapies under investigation include azithromycin, chloroquine, hydroxychloroquine, remdesivir, lopinavir/ritonavir, and favipiravir. Remdesivir is the only Food and Drug Administrationapproved drug for the use in adult and pediatric patients (>12 years old) for the treatment of this disease requiring hospitalization. In this context, the present review summarizes information about these drugs highlighting the chemical standpoint, such as physical-chemical and molecular characteristics, toxicity, history, and main applications, since knowledge about these substances is essential to assist the search for an appropriate treatment.","PeriodicalId":21315,"journal":{"name":"Revista Virtual de Química","volume":"116 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Virtual de Química","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21577/1984-6835.20220061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A novel SARS-CoV-2 coronavirus, the virus responsible for COVID-19, is a public health emergency of international concern since this infection spreads quickly through human-to-human transmission. Several drugs are being studied by researchers worldwide as an effective antiviral agent against this coronavirus. Therefore, most studies are focusing on drugs that have been already used earlier on the treatment of other diseases. Therapies under investigation include azithromycin, chloroquine, hydroxychloroquine, remdesivir, lopinavir/ritonavir, and favipiravir. Remdesivir is the only Food and Drug Administrationapproved drug for the use in adult and pediatric patients (>12 years old) for the treatment of this disease requiring hospitalization. In this context, the present review summarizes information about these drugs highlighting the chemical standpoint, such as physical-chemical and molecular characteristics, toxicity, history, and main applications, since knowledge about these substances is essential to assist the search for an appropriate treatment.
新冠肺炎潜在治疗药物评估的化学方法
新型SARS-CoV-2冠状病毒是导致COVID-19的病毒,是国际关注的突发公共卫生事件,因为这种感染通过人际传播迅速传播。世界各地的研究人员正在研究几种药物,作为对抗这种冠状病毒的有效抗病毒药物。因此,大多数研究都集中在早期已经用于治疗其他疾病的药物上。正在研究的治疗方法包括阿奇霉素、氯喹、羟氯喹、瑞德西韦、洛匹那韦/利托那韦和法匹拉韦。Remdesivir是美国食品和药物管理局(fda)唯一批准用于成人和儿童患者(>12岁)治疗这种需要住院治疗的疾病的药物。在此背景下,本综述总结了这些药物的信息,强调化学观点,如物理化学和分子特性,毒性,历史和主要应用,因为了解这些物质对于帮助寻找适当的治疗是必不可少的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信